tiprankstipranks
Beauty Health (DE:V7A0)
FRANKFURT:V7A0
Germany Market
V7A0
Beauty Health
RESEARCH TOOLSreports

Beauty Health (V7A0) Ratios

1 Followers

Beauty Health Ratios

DE:V7A0's free cash flow for Q2 2026 was $0.68. For the 2026 fiscal year, DE:V7A0's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.76 1.66 7.00 6.07 10.92
Quick Ratio
 1.48 1.40 5.99 5.28 9.39
Cash Ratio
 1.23 1.25 5.43 4.55 7.92
Solvency Ratio
 >-0.01 0.04 <0.01 -0.08 0.08
Operating Cash Flow Ratio
 0.13 0.20 0.24 0.19 -1.49
Short-Term Operating Cash Flow Coverage
 0.21 0.29 0.00 0.00 0.00
Net Current Asset Value
$ -135.80M$ -129.20M$ -156.76M$ -171.47M$ -52.76M
Leverage Ratios
Debt-to-Assets Ratio
 0.75 0.76 0.83 0.81 0.75
Debt-to-Equity Ratio
 6.60 6.20 10.97 12.67 4.50
Debt-to-Capital Ratio
 0.87 0.86 0.92 0.93 0.82
Long-Term Debt-to-Capital Ratio
 0.81 0.80 0.91 0.93 0.81
Financial Leverage Ratio
 8.75 8.18 13.24 15.64 6.00
Debt Service Coverage Ratio
 0.19 0.24 1.04 -3.79 6.01
Interest Coverage Ratio
 -0.17 -1.08 -6.51 -9.59 -1.93
Debt to Market Cap
 3.81 2.10 2.80 1.80 0.55
Interest Debt Per Share
 3.03 3.15 4.67 5.82 5.19
Net Debt to EBITDA
 5.57 3.77 19.16 -4.28 2.25
Profitability Margins
Gross Profit Margin
66.34%65.28%54.53%38.97%68.00%
EBIT Margin
0.56%4.45%-5.72%-22.17%16.05%
EBITDA Margin
9.96%12.88%3.09%-13.46%22.30%
Operating Profit Margin
-1.49%-6.92%-20.27%-32.89%-7.06%
Pretax Profit Margin
-8.18%-1.97%-8.84%-25.60%12.39%
Net Profit Margin
-9.79%-3.16%-8.70%-25.16%12.09%
Continuous Operations Profit Margin
-9.79%-3.16%-8.70%-25.16%12.09%
Net Income Per EBT
119.78%160.31%98.47%98.26%97.54%
EBT Per EBIT
550.46%28.54%43.60%77.83%-175.45%
Return on Assets (ROA)
-5.84%-1.90%-4.24%-10.78%4.41%
Return on Equity (ROE)
-47.84%-15.58%-56.17%-168.57%26.47%
Return on Capital Employed (ROCE)
-1.35%-6.64%-10.97%-16.08%-2.77%
Return on Invested Capital (ROIC)
-1.01%-4.70%-10.72%-15.71%-2.69%
Return on Tangible Assets
-8.60%-2.82%-5.65%-13.51%5.31%
Earnings Yield
-31.31%-5.42%-14.78%-24.45%3.29%
Efficiency Ratios
Receivables Turnover
 14.77 12.83 11.75 7.23 4.70
Payables Turnover
 6.06 6.69 6.93 5.43 4.11
Inventory Turnover
 2.09 2.18 2.20 2.66 1.07
Fixed Asset Turnover
 13.49 21.33 17.08 15.11 10.82
Asset Turnover
 0.60 0.60 0.49 0.43 0.36
Working Capital Turnover Ratio
 2.32 1.13 0.67 0.61 0.45
Cash Conversion Cycle
 139.49 141.69 144.35 120.43 330.66
Days of Sales Outstanding
 24.71 28.44 31.08 50.47 77.59
Days of Inventory Outstanding
 174.97 167.77 165.96 137.24 341.81
Days of Payables Outstanding
 60.19 54.53 52.69 67.28 88.73
Operating Cycle
 199.68 196.21 197.04 187.71 419.39
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 0.30 0.13 0.17 -0.72
Free Cash Flow Per Share
 0.13 0.26 0.08 0.07 -0.84
CapEx Per Share
 0.04 0.04 0.05 0.10 0.12
Free Cash Flow to Operating Cash Flow
 0.76 0.86 0.58 0.40 1.16
Dividend Paid and CapEx Coverage Ratio
 4.13 7.26 2.37 1.67 -6.13
Capital Expenditure Coverage Ratio
 4.13 7.26 2.37 1.67 -6.13
Operating Cash Flow Coverage Ratio
 0.06 0.10 0.03 0.03 -0.14
Operating Cash Flow to Sales Ratio
 0.08 0.12 0.05 0.05 -0.29
Free Cash Flow Yield
18.34%18.40%4.74%2.12%-9.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.10 -17.38 -6.91 -4.09 30.36
Price-to-Sales (P/S) Ratio
 0.31 0.58 0.59 1.03 3.67
Price-to-Book (P/B) Ratio
 1.63 2.88 3.80 6.90 8.04
Price-to-Free Cash Flow (P/FCF) Ratio
 5.45 5.43 21.08 47.07 -10.83
Price-to-Operating Cash Flow Ratio
 4.13 4.69 12.20 18.83 -12.60
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.27 0.10 0.01 -0.28
Price-to-Fair Value
 1.63 2.88 3.80 6.90 8.04
Enterprise Value Multiple
 8.71 8.30 38.20 -11.93 18.70
Enterprise Value
 251.72M 321.67M 394.98M 638.79M 1.53B
EV to EBITDA
 8.71 8.30 38.20 -11.93 18.70
EV to Sales
 0.87 1.07 1.18 1.61 4.17
EV to Free Cash Flow
 15.13 9.95 42.29 73.42 -12.31
EV to Operating Cash Flow
 11.46 8.58 24.48 29.37 -14.32
Tangible Book Value Per Share
 -0.78 -0.80 -0.96 -0.98 -0.03
Shareholders’ Equity Per Share
 0.43 0.48 0.42 0.45 1.13
Tax and Other Ratios
Effective Tax Rate
 -0.20 -0.60 0.02 0.02 0.02
Revenue Per Share
 2.24 2.38 2.70 3.02 2.48
Net Income Per Share
 -0.22 -0.08 -0.23 -0.76 0.30
Tax Burden
 1.20 1.60 0.98 0.98 0.98
Interest Burden
 -14.72 -0.44 1.54 1.15 0.77
Research & Development to Revenue
 0.02 0.02 0.02 0.03 0.02
SG&A to Revenue
 0.66 0.70 0.73 0.33 0.29
Stock-Based Compensation to Revenue
 0.04 0.05 0.08 0.06 0.08
Income Quality
 -0.77 -3.94 -0.55 -0.22 -2.40
Currency in USD